News Archive

The ADAPTABLE study, coordinated by the DCRI, will enroll as many as 15,000 cardiac patients to determine the optimal aspirin dose.

The report provides key insights from our faculty on a wide range of topics including translational science, clinical trials, open science, innovative technology, and the patient voice.

Laine Thomas, PhD, associate director of DCRI Biostatistics, sat down with David Page, PhD, chair of Duke Biostatistics & Bioinformatics, who is new to his role as of this year, for a discussion on the future of biomedical data science, as well as how machine learning techniques will be incorporated in this work.

The DCRI will serve as the coordinating center for ECHO, which will examine how environmental factors affect childhood health.

The IPF-PRO Registry will expand to target 1,500 patients at approximately 45 clinical sites nationwide.

The center will be a key component of the Trial Innovation Network, which is the newest part of the Clinical and Translational Science Award Program.

The DCRI’s Adrian Hernandez, MD, MHS, and Lesley Curtis, PhD, examined the challenges and opportunities of running one of the largest pragmatic clinical trials.

The study will be developing online tools highlighting the benefits and risks of different treatments to enable stroke patients to evaluate the treatment approach that suits them best.

Volunteers from the DCRI and other organizations will train fairgoers in compression-only CPR.